Autolus Therapeutics (AUTL) Inventory (2024 - 2026)
Autolus Therapeutics' (AUTL) quarterly Inventory came in at $33.2 million in Q4 2025, up 702.54% YoY from $4.1 million in Q4 2024, and up 19.79% on a QoQ basis from $27.7 million in Q3 2025.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Inventory (2024 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 2 years of Inventory data on file, last reported at $33.2 million in Q4 2025.
- Quarterly Inventory rose 702.54% year-over-year to $33.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.2 million (up 702.54% YoY) and the FY2025 annual result came in at $33.2 million, up 702.54% from the prior year.
- Inventory rose to $33.2 million in Q4 2025, from $27.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $33.2 million in Q4 2025 to a low of $4.1 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn | 33.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.43 Mn |
| Dec 31, 2025 | 33.21 Mn |
| Sep 30, 2025 | 27.72 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 14.65 Mn |
| Dec 31, 2024 | 4.14 Mn |